Colon cancer blood test offers new screening option
A blood test for colon cancer performed well in a study published Wednesday, offering a new kind of screening for a leading cause of cancer deaths.
The test looks for DNA fragments shed by tumor cells and precancerous growths. It’s already for sale in the U.S. for $895, but has not been approved by the Food and Drug Administration and most insurers do not cover it. The maker of the test, Guardant Health, anticipates an FDA decision this year.
In the study, the test caught 83% of the cancers but very few of the precancerous growths found by colonoscopy, the gold standard for colon cancer screening. Besides spotting tumors, colonoscopies can prevent the disease by removing precancerous growths called polyps.
But some people avoid the exam because of the hassle of getting time off work or the day-ahead preparation that involves drinking a strong laxative to empty the bowels.
Related articles
Georgia Republicans choose Amy Kremer, organizer of pro
COLUMBUS, Ga. (AP) — Georgia Republicans on Saturday elected to the Republican National Committee a2024-05-21Ted Lasso star Keeley Hazell leaves little to the imagination as she shows off her curves in a flesh
There's still a month of fixtures left to play, but Keeley Hazell appeared to be enjoying an early p2024-05-21Tommy Robinson is cleared of breaching dispersal order at march against anti
Tommy Robinson has walked free after being cleared of breaching a dispersal order at a march against2024-05-21Activists interrupt Chinese ambassador's Harvard speech — Radio Free Asia
A protester who loudly disrupted a speech at Harvard by Chinese Ambassador Xie Feng on the eve of a2024-05-21Insider Q&A: CIA's chief technologist's cautious embrace of generative AI
Knowledge advantage can save lives, win wars and avert disaster. At the Central Intelligence Agency,2024-05-21Hong Kong schools ban books, warn teachers not to get 'political' — Radio Free Asia
Hong Kong schools have been banning books, warning teachers not to express "political" views, traini2024-05-21
atest comment